• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱的浆母细胞性尿路上皮癌:一系列病例的临床病理、免疫组织化学、超微结构和分子分析。

Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.

机构信息

Division of Histology and Molecular Diagnostics, University Hospital Careggi, Viale G.B. Morgagni, Florence, Italy 50134.

出版信息

Hum Pathol. 2011 Aug;42(8):1149-58. doi: 10.1016/j.humpath.2010.11.011. Epub 2011 Feb 21.

DOI:10.1016/j.humpath.2010.11.011
PMID:21334719
Abstract

A plasmacytoid variant of urothelial carcinoma has been recently recognized in the World Health Organization classification system. This is characterized by a discohesive growth of plasmacytoid cells with eccentric nuclei, extending in the bladder wall and often in the perivesical adipose tissue. Herein, we report the clinicopathologic, immunohistochemical, ultrastructural, and molecular features of a series of plasmacytoid urothelial carcinoma of the urinary bladder. Four bladder carcinomas characterized by epithelial cells with morphologic appearance resembling plasma cells were evaluated at the immunohistochemical, electron microscopic, and molecular genetic levels. Tumor cells stained with cytokeratins, epithelial membrane antigen, GATA-3 (endothelial transcription factor 3), CD15, p53, and p16. In addition, malignant cells strongly stained with CD138 in all the cases, whereas leukocyte common antigen and multiple myeloma 1/interferon regulatory factor 4 were completely negative, nor immunoreactivity was seen for either κ or λ light chains. The electron microscopic examination showed the presence of divergent squamous and glandular differentiation. At variance with conventional urothelial carcinoma, the analysis of exons 4-9 of TP53 gene revealed no alteration in all the 4 tumors tested, and this can be of value in choosing additional chemotherapy after surgery. Plasmacytoid carcinoma of the bladder is a tumor entity, which can be characterized by specific immunohistochemical markers, including positivity for GATA-3, and presents phenotypic and genotypic peculiarities.

摘要

最近在世界卫生组织分类系统中认识到尿路上皮癌的浆母细胞变体。 其特征为浆母细胞的离散生长,具有偏心核,在膀胱壁中延伸,并且经常在膀胱周围脂肪组织中延伸。 在此,我们报告了一系列膀胱浆母细胞尿路上皮癌的临床病理,免疫组织化学,超微结构和分子特征。 在免疫组织化学,电子显微镜和分子遗传学水平上评估了 4 种具有类似于浆细胞形态的上皮细胞的膀胱癌。 肿瘤细胞用细胞角蛋白,上皮膜抗原,GATA-3(内皮转录因子 3),CD15,p53 和 p16 染色。 此外,在所有病例中恶性细胞均强烈染色 CD138,而白细胞共同抗原和多发性骨髓瘤 1/干扰素调节因子 4完全阴性,κ 或 λ 轻链也没有免疫反应性。 电子显微镜检查显示存在不同的鳞状和腺体分化。 与常规尿路上皮癌不同,在所有 4 个测试肿瘤中,TP53 基因外显子 4-9 的分析均未发现改变,这对于手术后选择其他化疗具有重要意义。 膀胱浆母细胞瘤是一种肿瘤实体,可以通过特定的免疫组织化学标志物来特征化,包括 GATA-3 的阳性表达,并表现出表型和基因型的特征。

相似文献

1
Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.膀胱的浆母细胞性尿路上皮癌:一系列病例的临床病理、免疫组织化学、超微结构和分子分析。
Hum Pathol. 2011 Aug;42(8):1149-58. doi: 10.1016/j.humpath.2010.11.011. Epub 2011 Feb 21.
2
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.胎盘S100(S100P)和GATA3:通过互补DNA微阵列发现的移行上皮和尿路上皮癌标志物。
Am J Surg Pathol. 2007 May;31(5):673-80. doi: 10.1097/01.pas.0000213438.01278.5f.
3
Plasmacytoid urothelial carcinoma of the bladder.膀胱浆细胞样尿路上皮癌
Hum Pathol. 2009 Jul;40(7):1023-8. doi: 10.1016/j.humpath.2009.01.001. Epub 2009 Mar 17.
4
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.膀胱尿路上皮癌,脂质细胞变异型:临床病理特征和杂合性缺失分析。
Am J Surg Pathol. 2010 Mar;34(3):371-6. doi: 10.1097/PAS.0b013e3181cd385b.
5
Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.膀胱浆细胞样移行细胞癌:9例临床病理研究
Am J Surg Pathol. 2008 May;32(5):752-7. doi: 10.1097/PAS.0b013e318159af9e.
6
Invasive micropapillary urothelial carcinoma of the bladder.膀胱浸润性微乳头状尿路上皮癌。
Hum Pathol. 2010 Aug;41(8):1159-64. doi: 10.1016/j.humpath.2009.11.018. Epub 2010 Apr 8.
7
Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.浆细胞样尿路上皮癌:17例形态学详细分析及临床病理相关性研究
Am J Surg Pathol. 2009 Mar;33(3):417-24. doi: 10.1097/PAS.0b013e318186c45e.
8
Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.具有脊索样特征的浸润性尿路上皮癌:12例以显著黏液样间质和索状上皮结构为特征的不同病例报告。
Am J Surg Pathol. 2009 Aug;33(8):1213-9. doi: 10.1097/PAS.0b013e3181a8ffbe.
9
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.具有内翻性生长模式的尿路上皮癌可通过荧光原位杂交、免疫组织化学和形态学分析与内翻性乳头状瘤相鉴别。
Am J Surg Pathol. 2007 Dec;31(12):1861-7. doi: 10.1097/PAS.0b013e318060cb9d.
10
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.膀胱浆细胞样尿路上皮癌:5例的组织学和临床特征
J Urol. 2008 Nov;180(5):1923-7. doi: 10.1016/j.juro.2008.07.035. Epub 2008 Sep 17.

引用本文的文献

1
Frequency and Characterization of Rare Histologic Subtypes in Canine Invasive Urothelial Carcinoma.犬浸润性尿路上皮癌中罕见组织学亚型的频率及特征
bioRxiv. 2025 May 14:2025.05.13.651218. doi: 10.1101/2025.05.13.651218.
2
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development.晚期膀胱癌尿路上皮和非尿路上皮亚型组织学的治疗进展:从病因到当前发展
Biomedicines. 2025 Jan 1;13(1):86. doi: 10.3390/biomedicines13010086.
3
Small Bowel Obstruction Secondary to Metastatic Urothelial Cell Carcinoma With Plasmacytoid Features: A Case Report.
伴浆细胞样特征的转移性尿路上皮细胞癌继发小肠梗阻:一例报告
Cureus. 2024 Jun 26;16(6):e63207. doi: 10.7759/cureus.63207. eCollection 2024 Jun.
4
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.浆细胞性尿路上皮癌的分子特征及其对治疗意义的影响。
Cancer Treat Res Commun. 2023;37:100779. doi: 10.1016/j.ctarc.2023.100779. Epub 2023 Nov 17.
5
Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.雌激素受体与 GATA3 在膀胱癌中的相关性:临床病理意义的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 8;12:684140. doi: 10.3389/fendo.2021.684140. eCollection 2021.
6
Unusual Faces of Bladder Cancer.膀胱癌的罕见表现
Cancers (Basel). 2020 Dec 10;12(12):3706. doi: 10.3390/cancers12123706.
7
Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.携带有 CDH-1 突变且产生高水平 CA 19-9 的转移性浆细胞性膀胱癌。病例报告及文献复习。
Am J Case Rep. 2020 Jul 9;21:e923130. doi: 10.12659/AJCR.923130.
8
Genomic Subtyping in Bladder Cancer.膀胱癌的基因组亚型分析。
Curr Urol Rep. 2020 Mar 13;21(2):9. doi: 10.1007/s11934-020-0960-y.
9
Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile.浆细胞样尿路上皮癌:一例具有独特临床病理和基因组特征的快速尸检病例报告。
Diagn Pathol. 2019 Oct 21;14(1):113. doi: 10.1186/s13000-019-0896-z.
10
Molecular and histopathology directed therapy for advanced bladder cancer.分子病理导向的晚期膀胱癌治疗。
Nat Rev Urol. 2019 Aug;16(8):465-483. doi: 10.1038/s41585-019-0208-0. Epub 2019 Jul 9.